The Hepatitis C Virus in Children

Unfortunately not enough is known about children with Hepatitis C because researchers and physicians have a difficult time tracking down children who suffer from this terrible infection.  There are two reasons for this. One is that children are less likely to show symptoms if they do have it and the second reason is that few of them are infected. Based on the way that people become infected with the Hepatitis C virus, also known as HCV, which is by blood-to-blood contact, this is not a surprise.  Children are not drug users, do not engage in unsafe sex nor are they as likely to be on dialysis or have blood transfusions.

Before changes in 1992, that improved blood testing making it more sensitive, and lowering infection risks to one in one hundred thousand, transfusions and maternal transfer were the ways that children were infected.  Its believed that a quarter of a million American children have Hepatitis C. The biggest issue here is that most of them remain untreated because no one knows they have the infection. Even the ones who have passed into the chronic stage only rarely show symptoms. If they do it may be that they are overly tired or even have some stomach pain that can't be easily defined.  But a doctor is unlikely to conclude from those that testing should be done for HCV.

Some studies have been conducted to try and understand how the Hepatitis C virus is passed to children and how their bodies deal with it. So far studies are inconclusive. They show that during heart surgeries there is more of a chance for a child to be infected by blood transfusion. But there is an equal chance of the child's body flushing the infection out, as there is that the child will remain infected. With adults there is a twenty five percent chance of having a spontaneous viral clearance.

Studies of children who have become infected by transmission from their mothers seem to pose as many questions as they answer.  For one thing it's not clear when the baby becomes infected. Researchers are not certain if it's in the womb or during the actual birth. They do know that it is not during breastfeeding, which is safe as long as the mother's nipples do not crack or bleed. Serum levels in these children are high for a short time and then seem to return to normal. But a liver biopsy will show that they have chronic hepatitis.

When treatment of children with Hepatitis C is begun in the acute stage its very successful. It appears that if only interferon is used in treatment, not in combination with anything, then the success rate is as high as seventy percent. But even these results pose questions for researchers. They do not know if it's the size of the dose, the smaller subject or a result of being able to track the disease's beginnings. Hopefully continued studies will conclude the best way to treat HCV in children.

Hepatitis news on the Web

Vertex, J&J Hepatitis C Drug Works After Others Fail - Bloomberg

Biomed Middle East

Vertex, J&J Hepatitis C Drug Works After Others Fail
Bloomberg
No proven medicines are available for hepatitis C patients who don't respond to standard care. If approved by the US Food and Drug Administration, ...
Vertex hepatitis C drug helps the hard-to-treatBusinessWeek
Vertex Maintains Lead Over Merck In Hepatitis CForbes (blog)
65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved ...MarketWatch (press release)
TheStreet.com -Xconomy -RTT News
all 36 news articles »

Bristol-Myers Squibb Hopes to Strengthen Hepatitis C Pipeline With Latest Buy - Seeking Alpha (blog)

The Star-Ledger - NJ.com

Bristol-Myers Squibb Hopes to Strengthen Hepatitis C Pipeline With Latest Buy
Seeking Alpha (blog)
Continuing its string of pearls philosophy, Bristol-Myers Squibb (BMY) has agreed to pay in cash for ZymoGenetics, which is developing a hepatitis C ...
Bristol-Myers Agrees to Acquire ZymoGeneticsNew York Times (blog)
Bristol-Myers Will Buy ZymoGenetics for $885 MillionBloomberg
Bristol-Myers Squibb to Acquire ZymoGeneticsMarketWatch (press release)
TheStreet.com -Pharma Times
all 335 news articles »

Idenix hep C drugs on clinical hold; shares plummet - Reuters

RTT News

Idenix hep C drugs on clinical hold; shares plummet
Reuters
O) said US health regulators halted all trials of two of its experimental hepatitis C drugs on safety concerns, putting the breaks on a potential ...
Idenix: Two Hep C Drugs on Clinical HoldTheStreet.com
Idenix Shares Plunge As FDA Puts Hepatitis C Drugs On Clinical Hold - UpdateRTT News
FDA halts Idenix Hep C drug targets on safety concernsMass High Tech
FierceBiotech -Bloomberg -Capital.gr (press release)
all 66 news articles »

Idenix shares slump on hepatitis C drug comments - Reuters

Idenix shares slump on hepatitis C drug comments
Reuters
... notice from the Food and Drug Administration that two of its experimental hepatitis C treatments have been put on clinical hold due to safety issues. ...

Mayo Clinic Hep C Letter Worries Patient - WJXT Jacksonville

Mayo Clinic Hep C Letter Worries Patient
WJXT Jacksonville
A man who is one of 3209 patients who may be at risk of contracting hepatitis C while at the Mayo Clinic said he's dealing with the very personal, ...
HSE STILL CALLING FOR GALWAY PATIENTS TO RECEIVE HEPATITIS TESTGalway News

all 2 news articles »

Intarcia Therapeutics raises $5M to treat long-term conditions - Reuters

Intarcia Therapeutics raises $5M to treat long-term conditions
Reuters
Intarcia Therapeutics, a biopharma company developing therapies for hepatitis C, type 2 diabetes and obesity, has raised $5 ...

Infected blood probe report due - The Press Association

Infected blood probe report due
The Press Association
An inquiry into why people were infected with hepatitis C and HIV from contaminated blood and blood products will publish its preliminary report. ...

and more »

Hepatitis C drug break-through - BBC News

MedIndia

Hepatitis C drug break-through
BBC News
Scientists at the Welsh School of Pharmacy say the first human clinical trials on a new drug to treat infections caused by the Hepatitis C virus have been ...
First clinical trials on potent new hepatitis C drug successfully completedSify
Cardiff hepatitis drug passes first trialWalesOnline
First clinical trials successfully completed on potent new hepatitis C drugEurekAlert (press release)
UPI.com
all 29 news articles »

Parents shocked by student HIV scare - ABC Online

ABC Online

Parents shocked by student HIV scare
ABC Online
Some of those students have still not been tested for hepatitis B, hepatitis C or HIV. The teacher used methylated spirits in an attempt to sterilise the ...
Students share needle in classSydney Morning Herald
18 Tasmanian Students Being Tested for Blood-Borne Diseases After Sharing ...TopNews United Kingdom (blog)
Students share needle in science classHerald Sun

all 27 news articles »

The Ticker - Boston Herald

The Ticker
Boston Herald
By Staff and wire reports Cambridge-based Idenix Pharmaceuticals said US health regulators halted all trials of two of its experimental hepatitis C drugs on ...


Google News